Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 2/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
| ▸ | PRCP | P42785 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8440321 | 0.89 | SLC1A1 (0.39) | NOS2NOS3NOS1DPP7PRCP | |
| SCHEMBL30716624 | 0.89 | QARS1 (0.40) | NOS2NOS3NOS1DPP7DPP4 | |
| SCHEMBL1275426 | 0.89 | ALOX15 (0.38) | NOS2NOS3NOS1DPP7PRCP | |
| SCHEMBL23757368 | 0.88 | SLC1A1 (0.38) | NOS2NOS3NOS1DPP7PRCP | |
| SCHEMBL3489282 | 0.86 | NOS2 (0.35) | NOS2NOS3NOS1DPP7PRCP | |
| SCHEMBL787736 | 0.83 | DPP7 (0.35) | NOS2NOS3NOS1DPP7PRCP | |
| SCHEMBL285831 | 0.82 | NOS2 (0.37) | NOS2NOS3NOS1DPP7PRCP | |
| SCHEMBL1537264 | 0.82 | DPP7 (0.40) | NOS2NOS3NOS1DPP7PRCP | |
| SCHEMBL4241080 | 0.82 | DPP7 (0.40) | NOS2NOS3NOS1DPP7PRCP | |
| SCHEMBL11660663 | 0.82 | DPP7 (0.40) | NOS2NOS3NOS1DPP7PRCP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0891771-A1 | Compositions comprising lysine and ascorbate compounds for the treatment and prevention of cardiovascular diseases | Health Now, Inc. (US) | 1999-01-20 | — | — | EP | claimed |
| CN-117269494-A | A group of metabolic markers for breast cancer lung metastasis | 厦门大学 | 2023-12-22 | — | — | CN | disclosed |
| US-20210060116-A1 | PEPTIDES AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | UNIV INDIANA RES & TECH CORP (US) | 2021-03-04 | — | — | US | disclosed |
| US-10864244-B2 | Peptides and methods for treatment of neurodegenerative diseases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2020-12-15 | — | — | US | disclosed |
| CN-108658243-B | Method for quickly removing organic pollutants in coal gas wastewater | 天津科技大学 | 2020-07-03 | — | — | CN | disclosed |
| US-20190054137-A1 | PEPTIDES AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION | 2019-02-21 | — | — | US | disclosed |
| CN-108658243-A | A kind of method of quick removal coal gas wastewater organic pollution | 天津科技大学 | 2018-10-16 | — | — | CN | disclosed |
| WO-2017147044-A1 | PEPTIDES AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2017-08-31 | — | — | WO | disclosed |
| US-7977550-B2 | Non-toxic endophytes, plants injected therewith and methods for injecting plants | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2011-07-12 | — | — | US | disclosed |
| US-20090255015-A1 | NON-TOXIC ENDOPHYTES, PLANTS INJECTED THEREWITH AND METHODS FOR INJECTING PLANTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS | 2009-10-08 | — | — | US | disclosed |
| US-20040157895-A1 | Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases | ARCTURUS BIOSCIENCE, INC. | 2004-08-12 | — | — | US | disclosed |
| CN-1477959-A | Compositions and methods for reducing plasma lipoprotein and risk factors for cardiovascular disease | — | 2004-02-25 | — | — | CN | disclosed |
| US-6693129-B2 | A BIOCHEMICAL FORMULATION COMPRISING ASCORBIC ACID, NIACIN, LYSINE, AND PROLINE USEFUL FOR LOWERING PLASMA CONCENTRATION OF A LIPOPROTEIN IN MAMMAL | Rath, Matthias | 2004-02-17 | — | — | US | disclosed |
| EP-1324753-A2 | COMPOSITIONS AND METHODS FOR LOWERING PLASMA LIPOPROTEIN(A) AND RISK FACTORS OF CARDIOVASCULAR DISEASES | Rath, Matthias (US) | 2003-07-09 | — | — | EP | disclosed |
| US-20030064055-A1 | Non-toxic endophytes, plants injected therewith and methods for injecting plants | WEST CHARLES P (US) | 2003-04-03 | — | — | US | disclosed |
| US-20020094996-A1 | Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases | RATH MATTHIAS (NL) | 2002-07-18 | — | — | US | disclosed |
| WO-2002028379-A2 | COMPOSITIONS AND METHODS FOR LOWERING PLASMA LIPOPROTEIN(A) AND RISK FACTORS OF CARDIOVASCULAR DISEASES | RATH MATTHIAS (US) | 2002-04-11 | — | — | WO | disclosed |
| WO-2002013616-A2 | PLANTS INFECTED WITH NON-TOXIC ENDOPHYTES | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2002-02-21 | — | — | WO | disclosed |
| EP-0891771-A1 | Compositions comprising lysine and ascorbate compounds for the treatment and prevention of cardiovascular diseases | Health Now, Inc. (US) | 1999-01-20 | — | — | EP | disclosed |
| US-5438120-A | Purified Bordetella pertussius antigen used in vaccine against whooping cough; side effect reduction | BURROUGHS WELLCOME CO. (US) | 1995-08-01 | — | — | US | disclosed |